Brain, Vol. 118, No. 2, 547-563, 1995
© 1995 Oxford University Press
review-article |
The skeletal muscle sodium and chloride channel diseases
Department of Clinical Neurological Sciences and The Richard Ivey Centre for Molecular Biology, University Hospital London, Ontario, Canada
Correspondence to:
Correspondence to: A. J. Hudson, Department of Clinical Neurological Sciences, University Hospital, 339 Windermere Road, London, Ontario, Canada N6A 5A5
The cause of several familial muscular diseases have recently been linked to mutations within skeletal muscle sodium and chloride channel genes. Thomsen's and Becker's diseases are autosomal dominant and recessive, respectively, and are caused by at least seven different mutations in the CLCNI (ClC-1) skeletal muscle chloride channel gene on chromosome 7q35. Hyperkalaemic periodic paralysis, paramyotonia congenita and a small heterogeneous group of related pure myotonias are autosomal dominant disorders and are due to at least 16 different mutations in the SCN4A (SkMl) adult skeletal muscle sodium channel gene on chromosome 17q23–25. There is generally little correlation between the position of a mutation in the channel and the phenotype. Indeed, identical sodium channel mutations in unrelated subjects and sometimes in different members of the same family can have different clinical expressions. It seems, however, that mutations of the inactivation gate (ID3–4 loop) of the sodium channel tend to produce paramyotonia or pure, sometimes severe, myotonia and respond most favourably to the same medications (tocainide and mexiletine). The structure and polarity of substituted amino acids at a mutation site, especially in highly evolutionally conserved regions of the gene, are undoubtably important to the expression of a channel disease and may partly explain phenotypic variability. In addition, genetic polymorphisms elsewhere, either in the gene or other channel-related loci, and the net effect of other types of muscle ion channels on the electrical potential of the plasma membrane probably contribute to disease expression.
myotonia; periodic paralysis; sodium channel; cholride channel
Received May 31, 1994. Revised October 5, 1994. Accepted November 21, 1994.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Rossignol, J. Mathieu, I. Thiffault, M. Tetreault, M. -J. Dicaire, N. Chrestian, N. Dupre, J. Puymirat, and B. Brais A novel founder SCN4A mutation causes painful cold-induced myotonia in French-Canadians Neurology, November 13, 2007; 69(20): 1937 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ulbricht Sodium Channel Inactivation: Molecular Determinants and Modulation Physiol Rev, October 1, 2005; 85(4): 1271 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Tsang, R. G. Tsushima, G. F. Tomaselli, R. A. Li, and P. H. Backx A Multifunctional Aromatic Residue in the External Pore Vestibule of Na+ Channels Contributes to the Local Anesthetic Receptor Mol. Pharmacol., February 1, 2005; 67(2): 424 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shirakawa, K. Sakai, Y. Kitagawa, A. Hori, and G. Hirose A novel murine myotonia congenita without molecular defects in the ClC-1 and the SCN4A Neurology, October 8, 2002; 59(7): 1091 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P Takahashi and S. C Cannon Mexiletine block of disease-associated mutations in S6 segments of the human skeletal muscle Na+ channel J. Physiol., December 15, 2001; 537(3): 701 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Kim, Y Hahn, E H Sohn, Y J Lee, J H Yun, J M Kim, and J H Chung Phenotypic variation of a Thr704Met mutation in skeletal sodium channel gene in a family with paralysis periodica paramyotonica J. Neurol. Neurosurg. Psychiatry, May 1, 2001; 70(5): 618 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S M Zuberi and M G Hanna Current topic: Ion channels and neurology Arch. Dis. Child., March 1, 2001; 84(3): 277 - 280. [Full Text]
|
|
|
|
 |
|
 G. Drost, J. H. Blok, D. F. Stegeman, J. P. van Dijk, B. G. M. van Engelen, and M. J. Zwarts Propagation disturbance of motor unit action potentials during transient paresis in generalized myotonia: A high-density surface EMG study Brain, February 1, 2001; 124(2): 352 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Dutta, M Fischler, and A McClung Angiotensin converting enzyme inhibitor induced hyperkalaemic paralysis Postgrad. Med. J., February 1, 2001; 77(904): 114 - 115. [Abstract] [Full Text]
|
|
|
|
|
|
D. E. Bulman, K. A. Scoggan, M. D. van Oene, M. W. Nicolle, A. F. Hahn, L. L. Tollar, and G. C. Ebers A novel sodium channel mutation in a family with hypokalemic periodic paralysis Neurology, December 1, 1999; 53(9): 1932 - 1932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Lehmann-Horn and K. Jurkat-Rott Voltage-Gated Ion Channels and Hereditary Disease Physiol Rev, October 1, 1999; 79(4): 1317 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Li, R. G. Tsushima, K. Himmeldirk, D. S. Dime, and P. H. Backx Local Anesthetic Anchoring to Cardiac Sodium Channels : Implications Into Tissue-Selective Drug Targeting Circ. Res., July 9, 1999; 85(1): 88 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Otsuka, T. Ogura, T. Yamauchi, and H. Makino Congenital Adrenal Hyperplasia With Normokalemic Periodic Paralysis Arch Neurol, November 1, 1998; 55(11): 1487 - 1487. [Full Text] [PDF]
|
|
|
|
|
|
M. G HANNA, N. W WOOD, and D. M KULLMANN Ion channels and neurological disease: DNA based diagnosis is now possible, and ion channels may be important in common paroxysmal disorders J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 427 - 431. [Full Text]
|
|
|
|
|
|
R. W Orrell, K. Jurkat-Rott, F. Lehmann-Horn, and R. J M Lane Familial cramp due to potassium-aggravated myotonia J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 569 - 572. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. L. Sah, R. G. Tsushima, and P. H. Backx Effects of local anesthetics on Na+ channels containing the equine hyperkalemic periodic paralysis mutation Am J Physiol Cell Physiol, August 1, 1998; 275(2): C389 - C400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T T WARNER and P JARMAN The molecular genetics of the dystonias J. Neurol. Neurosurg. Psychiatry, April 1, 1998; 64(4): 427 - 429. [Full Text] [PDF]
|
|
|
|
|
|
S. Evers, A. Engelien, V. Karsch, and M. Hund Secondary hyperkalaemic paralysis J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 249 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Ackerman and D. E. Clapham Ion Channels -- Basic Science and Clinical Disease N. Engl. J. Med., May 29, 1997; 336(22): 1575 - 1586. [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Hall, G. Gu, J. Garcia-Anoveros, L. Gong, M. Chalfie, and M. Driscoll Neuropathology of Degenerative Cell Death in Caenorhabditis elegans J. Neurosci., February 1, 1997; 17(3): 1033 - 1045. [Abstract] [Full Text] [PDF]
|
|